WASHINGTON (AP) -- A novel antibiotic linked to rare reports of severe liver problems, including several deaths, will be subjected to new scrutiny by federal health advisers, according to a document released Tuesday.
WASHINGTON (AP) -- A novel antibiotic linked to rare reports of severe liver problems, including several deaths, will be subjected to new scrutiny by federal health advisers, according to a document released Tuesday.
